相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Preliminary Clinical Study of the Effect of Ascorbic Acid on Colistin-Associated Nephrotoxicity
Rujipas Sirijatuphat et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2015)
Excess Mortality Associated With Colistin-Tigecycline Compared With Colistin-Carbapenem Combination Therapy for Extensively Drug-Resistant Acinetobacter baumannii Bacteremia: A Multicenter Prospective Observational Study
Aristine Cheng et al.
CRITICAL CARE MEDICINE (2015)
Association Between Colistin Dose and Development of Nephrotoxicity
Yu-Ji Lee et al.
CRITICAL CARE MEDICINE (2015)
Colistin treatment in carbapenem-resistant Acinetobacter baumannii pneumonia patients: Incidence of nephrotoxicity and outcomes
Ki Hwan Kwon et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2015)
Incidence and Risk Factors for Colistin-Associated Nephrotoxicity
Fatih Temocin et al.
JAPANESE JOURNAL OF INFECTIOUS DISEASES (2015)
Risk factors for acute kidney injury (AKI) in patients treated with polymyxin B and influence of AKI on mortality: a multicentre prospective cohort study
Maria Helena Rigatto et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2015)
Colistin and neurotoxicity: recommendations for optimal use in cystic fibrosis patients
Barbara O. M. Claus et al.
INTERNATIONAL JOURNAL OF CLINICAL PHARMACY (2015)
Colistin alone or combined with sulbactam or carbapenem against A. baumannii in ventilator-associated pneumonia
Gul Ruhsar Yilmaz et al.
JOURNAL OF INFECTION IN DEVELOPING COUNTRIES (2015)
Treatment of Ventilator-Associated Pneumonia Using Intravenous Colistin Alone or in Combination with Inhaled Colistin in Critically Ill Children
Meltem Polat et al.
PEDIATRIC DRUGS (2015)
High dose intravenous colistin methanesulfonate therapy is associated with high rates of nephrotoxicity; a prospective cohort study from Saudi Arabia
Ali S. Omrani et al.
ANNALS OF CLINICAL MICROBIOLOGY AND ANTIMICROBIALS (2015)
Adverse Reactions Associated with Systemic Polymyxin Therapy
Julie Ann Justo et al.
PHARMACOTHERAPY (2015)
In Vitro Assessment and Multicenter Cohort Study of Comparative Nephrotoxicity Rates Associated with Colistimethate versus Polymyxin B Therapy
Kady Phe et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2014)
Colistin for the treatment of ventilator-associated pneumonia caused by multidrug-resistant Gram-negative bacteria: A systematic review and meta-analysis
Wan-Jie Gua et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2014)
Risk factors for acute kidney injury in patients treated with polymyxin B or colistin methanesulfonate sodium
Felipe F. Tuon et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2014)
Colistin nephrotoxicity increases with age
Ilker Inanc Balkan et al.
SCANDINAVIAN JOURNAL OF INFECTIOUS DISEASES (2014)
Megalin Contributes to Kidney Accumulation and Nephrotoxicity of Colistin
Takahiro Suzuki et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2013)
Nephrotoxicity and Efficacy Assessment of Polymyxin Use in 92 Transplant Patients
Marcelo M. Mostardeiro et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2013)
Trough colistin plasma level is an independent risk factor for nephrotoxicity: a prospective observational cohort study
Luisa Sorli et al.
BMC INFECTIOUS DISEASES (2013)
Association Between Colistin Dose and Microbiologic Outcomes in Patients With Multidrug-Resistant Gram-Negative Bacteremia
Giulia Vicari et al.
CLINICAL INFECTIOUS DISEASES (2013)
Population Pharmacokinetics of Intravenous Polymyxin B in Critically Ill Patients: Implications for Selection of Dosage Regimens
Ana M. Sandri et al.
CLINICAL INFECTIOUS DISEASES (2013)
Higher Incidence of Acute Kidney Injury With Intravenous Colistimethate Sodium Compared With Polymyxin B in Critically Ill Patients at a Tertiary Care Medical Center
Darowan S. Akajagbor et al.
CLINICAL INFECTIOUS DISEASES (2013)
Colistin vs. the combination of colistin and rifampicin for the treatment of carbapenem-resistant Acinetobacter baumannii ventilator-associated pneumonia
H. Aydemir et al.
EPIDEMIOLOGY AND INFECTION (2013)
Intravenous colistin in a patient with serious burns and borderline syndrome: The benefits of therapeutic drug monitoring
Stefanie M. Bode-Boeger et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2013)
Novel derivatives of polymyxins
Martti Vaara
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2013)
Emergent Renal Dysfunction with Colistin Pharmacotherapy
Julie M. Collins et al.
PHARMACOTHERAPY (2013)
Risk factors for acute kidney injury in critically ill patients receiving high intravenous doses of colistin methanesulfonate and/or other nephrotoxic antibiotics: a retrospective cohort study
Monica Rocco et al.
CRITICAL CARE (2013)
Effectiveness and Tolerability of a Polymyxin B Dosing Protocol
Diana Esaian et al.
ANNALS OF PHARMACOTHERAPY (2012)
Incidence and Predictors of Nephrotoxicity Associated with Intravenous Colistin in Overweight and Obese Patients
Timothy P. Gauthier et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2012)
What Is the Efficacy and Safety of Colistin for the Treatment of Ventilator-Associated Pneumonia? A Systematic Review and Meta-Regression
Diana F. Florescu et al.
CLINICAL INFECTIOUS DISEASES (2012)
High-Dose, Extended-Interval Colistin Administration in Critically Ill Patients: Is This the Right Dosing Strategy? A Preliminary Study
Lidia Dalfino et al.
CLINICAL INFECTIOUS DISEASES (2012)
Colistin therapy in critically ill patients with chronic renal failure and its effect on development of renal dysfunction
Melda Turkoglu et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2012)
Ascorbic acid protects against the nephrotoxicity and apoptosis caused by colistin and affects its pharmacokinetics
Jumana M. Yousef et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2012)
Incidence and predictors of acute kidney injury associated with intravenous polymyxin B therapy
Christine J. Kubin et al.
JOURNAL OF INFECTION (2012)
Polymyxin B self-associated with phospholipid nanomicelles
Kenneth S. Brandenburg et al.
PHARMACEUTICAL DEVELOPMENT AND TECHNOLOGY (2012)
Melatonin Attenuates Colistin-Induced Nephrotoxicity in Rats
Jumana M. Yousef et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2011)
Population Pharmacokinetics of Colistin Methanesulfonate and Formed Colistin in Critically Ill Patients from a Multicenter Study Provide Dosing Suggestions for Various Categories of Patients
S. M. Garonzik et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2011)
Incidence of and Risk Factors for Colistin-Associated Nephrotoxicity in a Large Academic Health System
Jason M. Pogue et al.
CLINICAL INFECTIOUS DISEASES (2011)
Risk factors for colistin-associated nephrotoxicity
Pinyo Rattanaumpawan et al.
JOURNAL OF INFECTION (2011)
Early Acute Kidney Injury Is a Risk Factor That Predicts Mortality in Patients Treated with Colistin
Hee ja Ko et al.
NEPHRON CLINICAL PRACTICE (2011)
Nephrotoxicity Associated with Intravenous Colistin in Critically Ill Patients
Neha M Doshi et al.
PHARMACOTHERAPY (2011)
Elucidation of the Pharmacokinetic/Pharmacodynamic Determinant of Colistin Activity against Pseudomonas aeruginosa in Murine Thigh and Lung Infection Models
Rajesh V. Dudhani et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2010)
Colistin Dosing and Nephrotoxicity in a Large Community Teaching Hospital
C. Andrew DeRyke et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2010)
Aerosolized plus Intravenous Colistin versus Intravenous Colistin Alone for the Treatment of Ventilator-Associated Pneumonia: A Matched Case-Control Study
Diamantis P. Kofteridis et al.
CLINICAL INFECTIOUS DISEASES (2010)
Inhaled colistin as adjunctive therapy to intravenous colistin for the treatment of microbiologically documented ventilator-associated pneumonia: a comparative cohort study
I. P. Korbila et al.
CLINICAL MICROBIOLOGY AND INFECTION (2010)
Predictors of acute kidney injury associated with intravenous colistin treatment
Jeong-Ah Kwon et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2010)
Colistin therapy for microbiologically documented multidrug-resistant Gram-negative bacterial infections: a retrospective cohort study of 258 patients
Matthew E. Falagas et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2010)
Safety and efficacy of intravenous colistin (colistin methanesulphonate) for severe multidrug-resistant Gram-negative bacterial infections
Chien-Yu Cheng et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2010)
Randomized controlled trial of nebulized colistimethate sodium as adjunctive therapy of ventilator-associated pneumonia caused by Gram-negative bacteria
Pinyo Rattanaumpawan et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2010)
The impact of polymyxin B dosage on in-hospital mortality of patients treated with this antibiotic
Laura S. Elias et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2010)
Effectiveness and safety of colistin: prospective comparative cohort study
Mical Paul et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2010)
Prevalence and Risk Factors for Acute Kidney Injury Associated with Parenteral Polymyxin B Use
Carlos A. C. Mendes et al.
ANNALS OF PHARMACOTHERAPY (2009)
Population Pharmacokinetic Analysis of Colistin Methanesulfonate and Colistin after Intravenous Administration in Critically Ill Patients with Infections Caused by Gram-Negative Bacteria
D. Plachouras et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2009)
Nephrotoxicity Associated with Intravenous Colistin (Colistimethate Sodium) Treatment at a Tertiary Care Medical Center
Joshua D. Hartzell et al.
CLINICAL INFECTIOUS DISEASES (2009)
Polymyxin B and colistimethate are comparable as to efficacy and renal toxicity
Maura S. Oliveira et al.
DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE (2009)
Effectiveness and Safety of Colistin for the Treatment of Multidrug-Resistant Pseudomonas aeruginosa Infections
M. Montero et al.
INFECTION (2009)
Systemic colistin use in children without cystic fibrosis: a systematic review of the literature
Matthew E. Falagas et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2009)
Clinical characteristics and risk factors of colistin-induced nephrotoxicity
Jieun Kim et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2009)
Colistin serum concentrations after intravenous administration in critically ill patients with serious multidrug-resistant, gram-negative bacilli infections: A prospective, open-label, uncontrolled study
Nikolaos Markou et al.
CLINICAL THERAPEUTICS (2008)
Continuous versus intermittent infusion of polymyxin B in the treatment of infections caused by multidrug-resistant Gram-negative bacteria
Christine B. Teng et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2008)
Intravenous colistin sulphomethate sodium for therapy of infections due to multidrug-resistant gram-negative, bacteria
Vicente Pintado et al.
JOURNAL OF INFECTION (2008)
Efficacy and safety of high-dose ampicillin/sulbactam vs. colistin as monotherapy for the treatment of multidrug resistant Acinetobacter baumannii ventilator-associated pneumonia
Alex P. Betrosian et al.
JOURNAL OF INFECTION (2008)
Efficacy and safety of colistin (colistimethate sodium) for therapy of infections caused by multidrug-resistant Pseudomonas aeruginosa and Acinetobacter baumannii in Siriraj Hospital, Bangkok, Thailand
Pornpan Koomanachai et al.
INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES (2007)
Safety and efficacy of colistin compared with imipenem in the treatment of ventilator-associated pneumonia: a matched case-control study
H. Kallel et al.
INTENSIVE CARE MEDICINE (2007)
Effectiveness and nephrotoxicity of colistin monotherapy vs. colistin-meropenem combination therapy for multidrug-resistant Gram-negative bacterial infections
M. E. Falagas et al.
CLINICAL MICROBIOLOGY AND INFECTION (2006)
Polymyxin B and doxycycline use in patients with multidrug-resistant Acinetobacter baumannii infections in the intensive care unit
Katherine P. Holloway et al.
ANNALS OF PHARMACOTHERAPY (2006)
Toxicity of polymyxins: a systematic review of the evidence from old and recent studies
Matthew E. Falagas et al.
CRITICAL CARE (2006)
Colistin: the re-emerging antibiotic for multidrug-resistant Gram-negative bacterial infections
Jian Li et al.
LANCET INFECTIOUS DISEASES (2006)
Nephrotoxicity of intravenous colistin: a prospective evaluation
ME Falagas et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2005)
Pharmacodynamics of polymyxin B against Pseudomonas aeruginosa
VH Tam et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2005)
Safety and efficacy of colistin in Acinetobacter and Pseudomonas infections:: a prospective cohort study
R Reina et al.
INTENSIVE CARE MEDICINE (2005)
Combination therapy with intravenous colistin for management of infections due to multidrug-resistant gram-negative bacteria in patients without cystic fibrosis
SK Kasiakou et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2005)
Cure of post-traumatic recurrent multiresistant gram-negative rod meningitis with intraventricular colistin
SK Kasiakou et al.
JOURNAL OF INFECTION (2005)
Colistin: The revival of polymyxins for the management of multidrug-resistant gram-negative bacterial infections
ME Falagas et al.
CLINICAL INFECTIOUS DISEASES (2005)
Colistin treatment in patients with ICU-acquired infections caused by multiresistant Gram-negative bacteria: the renaissance of an old antibiotic
AS Michalopoulos et al.
CLINICAL MICROBIOLOGY AND INFECTION (2005)
Bronchial constriction and inhaled colistin in cystic fibrosis
GA Alothman et al.
CHEST (2005)
Toxicity after prolonged (more than four weeks) administration of intravenous colistin
ME Falagas et al.
BMC INFECTIOUS DISEASES (2005)
Colistin interactions with the mammalian urothelium
JR Lewis et al.
AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY (2004)
Combination therapy with polymyxin B for the treatment of multidrug-resistant Gram-negative respiratory tract infections
ME Sobieszczyk et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2004)
Intravenous colistin in the treatment of sepsis from multiresistant Gram-negative bacilli in critically ill patients
N Markou et al.
CRITICAL CARE (2003)
Polymyxin B nephrotoxicity and efficacy against nosocomial infections caused by multiresistant gram-negative bacteria
JP Ouderkirk et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2003)
Stability of colistin and colistin methanesulfonate in aqueous media and plasma as determined by high-performance liquid chromatography
J Li et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2003)
Steady-state pharmacokinetics of intravenous colistin methanesulphonate in patients with cystic fibrosis
J Li et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2003)
分享论文
